Soligenix (SNGX) Stock Surges on FDA Orphan Drug Designation for Rare Disease Treatment – A Big Win for This Biotech Underdog
Hey there, traders and investors! If you’re scanning the markets today looking for that one stock that’s lighting up the boards, let me tell you about Soligenix (SNGX). This little biotech player is absolutely exploding higher, and it’s all thanks to some fresh news from the FDA that could be a game-changer for patients dealing … Read more